none21noFull-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We studied their interaction in hybrid transgenic mice bearing human full-length HER2 and Delta16 (F1 HER2/Delta16) in comparison to parental HER2 and Delta16 transgenic mice. Mammary carcinomas onset was faster in F1 HER2/Delta16 and Delta16 than in HER2 mice, however tumor growth was slower, and metastatic spread was comparable in all transgenic mice. Full-length HER2 tumors contained few large vessels or vascular lacunae, whereas Delta16 tumors presented a more regular vascularization with numerous endothelium-lined small vessels. Delta16-expressing tumors showed a higher accumulation of i.v. injected doxorubicin than tumors expressin...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
The human epidermal growth factor receptor 2 (HER2) is a validated therapeutic target in breast canc...
Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We ...
Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We...
HER-2 gene products found in human breast cancer include the full-length p185 oncoprotein and variou...
Several transgenic mice models solidly support the hypothesis that HER2 (ERBB2) overexpression or mu...
We have previously shown that the d16HER2 splice variant is linked to HER2-positive breast cancer (B...
Almost 90% of human primary breast cancers (BCs) express 4-9% of total wild-type (WT) HER2 as a spli...
The HER2 splice variant characterized by the deletion of exon 16 and denominated as d16HER2, is asso...
Deep insight on delta16HER2 splice variant and its role in HER2-overexpressing breast cancer
Several transgenic mice models solidly support the hypothesis that HER2 (ERBB2) overexpression or mu...
HER-2 is a 185 kDa transmembrane receptor tyrosine kinase that belongs to the EGFR family. HER-2 is ...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
The human epidermal growth factor receptor 2 (HER2) is a validated therapeutic target in breast canc...
Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We ...
Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We...
HER-2 gene products found in human breast cancer include the full-length p185 oncoprotein and variou...
Several transgenic mice models solidly support the hypothesis that HER2 (ERBB2) overexpression or mu...
We have previously shown that the d16HER2 splice variant is linked to HER2-positive breast cancer (B...
Almost 90% of human primary breast cancers (BCs) express 4-9% of total wild-type (WT) HER2 as a spli...
The HER2 splice variant characterized by the deletion of exon 16 and denominated as d16HER2, is asso...
Deep insight on delta16HER2 splice variant and its role in HER2-overexpressing breast cancer
Several transgenic mice models solidly support the hypothesis that HER2 (ERBB2) overexpression or mu...
HER-2 is a 185 kDa transmembrane receptor tyrosine kinase that belongs to the EGFR family. HER-2 is ...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
A splice isoform of the HER2 receptor that lacks exon 16 (d16HER2) is expressed in many HER2-positiv...
The human epidermal growth factor receptor 2 (HER2) is a validated therapeutic target in breast canc...